ClinConnect ClinConnect Logo
Search / Trial NCT06872814

Vaccine Hesitancy in Patients with Solid Tumors: a Cross-sectional Single-center Survey

Launched by FONDAZIONE IRCCS POLICLINICO SAN MATTEO DI PAVIA · Mar 7, 2025

Trial Information

Current as of April 26, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. \>18 years of age;
  • 2. Oncology patient defined as a patient with solid tumors undergoing active systemic treatment or follow-up;
  • 3. Written informed consent
  • Exclusion Criteria:
  • 1. Patients with hematological tumors
  • 2. Patients who are unable to understand informed consent document

About Fondazione Irccs Policlinico San Matteo Di Pavia

Fondazione IRCCS Policlinico San Matteo di Pavia is a prestigious research hospital and clinical trial sponsor located in Italy, dedicated to advancing medical knowledge and improving patient care through innovative research. As a leading institution in the fields of clinical and translational medicine, the foundation actively conducts trials across various therapeutic areas, emphasizing rigorous scientific methodologies and adherence to ethical standards. With a commitment to fostering collaboration among healthcare professionals, researchers, and patients, Fondazione IRCCS Policlinico San Matteo serves as a pivotal contributor to the development of new treatments and healthcare solutions, ultimately enhancing patient outcomes and public health.

Locations

Pavia, , Italy

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported